Cancer research
Since its inception in 2016, MIB Agents, a leading pediatric osteosarcoma nonprofit, has awarded $2.5 million to scientists across the country through its grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise research dollars in honor of an OsteoWarrior
Cancer research
A new study published in the Journal of the American Heart Association has found that body mass index (BMI) and glycemic status significantly affect cardiovascular risks in cancer patients undergoing anthracycline-based chemotherapy. The research, led by Iokfai Cheang and colleagues from Jiangsu Province Hospital, analyzed data from 11,393 chemotherapy-naive
Cancer research
A groundbreaking multicenter study, sponsored by University Hospital Southampton NHS Foundation Trust, has been initiated to improve early detection of pancreatic cancer in individuals recently diagnosed with type 2 diabetes. The Surveillance of pAncreatic health aFter diabEtes Diagnosis (SAFE-D) study aims to recruit up to 15,000 patient participants and
Cancer research
The metastatic prostate cancer market is witnessing a transformative shift towards precision medicine, driven by the development of targeted therapies, precision treatment approaches, and combination therapies. This trend is fueled by the increasing need for more effective and personalized treatments that improve patient outcomes and quality of life. Key players
Cancer research
Research published in the Journal of Trace Elements In Medicine and Biology has identified potential early diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC) by integrating trace element and oxidative stress profiling with machine learning. The study investigated alterations in trace elements and oxidative stress-related biomarkers in cancerous and adjacent
Cancer research
Computed tomography colonography (CTC) is a safe and minimally invasive method for colorectal cancer (CRC) screening that is both clinically effective and cost-effective, according to a study published in Radiology. Researchers compared CTC with multitarget stool DNA (mt-sDNA) testing and found that CTC is more effective at preventing and detecting
Cancer research
Researchers from the University of Baghdad have conducted a case-control study to investigate the relationship between nonalcoholic fatty liver disease (NAFLD) and the risk of colorectal cancer (CRC). The study involved 60 participants and found that liver function enzymes, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase
Cancer research
A new study has shed light on the potential anti-lung cancer effects of cortex mori, a natural compound derived from the Morus alba plant. Researchers from the Department of Pharmacy at the Tenth Affiliated Hospital of Southern Medical University in Dongguan, China, conducted a network pharmacology study to investigate the
Cancer research
New research from Lincoln Memorial University has identified significant disparities in lung cancer screening recommendations across different demographic groups. The study analyzed data from the National Lung Screening Trial (NLST) and found that certain factors, such as alcohol consumption, age, sex, and ethnicity, influence a radiologist's decision to
Cancer research
A new study published in Cancer has found that states with Medicaid expansion and paid sick leave laws have a significantly higher rate of colon cancer screening among adults aged 50-75. The research, conducted by a team of investigators at the University of Texas Southwestern Medical Center Dallas, analyzed data
Cancer research
A recent study published in Pediatric Blood & Cancer has investigated the incidence and risk factors of bloodstream infection (BSI) and invasive fungal infection (IFI) in pediatric acute myeloid leukemia (pAML) patients treated according to various protocols between 1998 and 2014. The study found that the cumulative incidence of any
Cancer research
Researchers at Jilin University have developed a novel ER-targeted PEGylated liposome (ES-SSL-PTX/CDDP) coencapsulating paclitaxel (PTX) and cisplatin (CDDP) to enhance therapeutic efficacy and mitigate systemic toxicity in the treatment of ovarian cancer. The research demonstrates the potential of this targeted delivery system to improve the efficacy and reduce the
